These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9490020)

  • 1. The first constant domain (C(H)1 and C(L)) of an antibody used as heterodimerization domain for bispecific miniantibodies.
    Müller KM; Arndt KM; Strittmatter W; Plückthun A
    FEBS Lett; 1998 Jan; 422(2):259-64. PubMed ID: 9490020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dimeric bispecific miniantibody combines two specificities with avidity.
    Müller KM; Arndt KM; Plückthun A
    FEBS Lett; 1998 Jul; 432(1-2):45-9. PubMed ID: 9710248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.
    Connelly RJ; Hayden MS; Scholler JK; Tsu TT; Dupont B; Ledbetter JA; Kanner SB
    Int Immunol; 1998 Dec; 10(12):1863-72. PubMed ID: 9885907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and production of novel tetravalent bispecific antibodies.
    Coloma MJ; Morrison SL
    Nat Biotechnol; 1997 Feb; 15(2):159-63. PubMed ID: 9035142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient route to the production of an IgG-like bispecific antibody.
    Zuo Z; Jimenez X; Witte L; Zhu Z
    Protein Eng; 2000 May; 13(5):361-7. PubMed ID: 10835110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
    Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
    Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.
    Chen W; Bardhi A; Feng Y; Wang Y; Qi Q; Li W; Zhu Z; Dyba MA; Ying T; Jiang S; Goldstein H; Dimitrov DS
    MAbs; 2016; 8(4):761-74. PubMed ID: 26963639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli.
    Pack P; Kujau M; Schroeckh V; Knüpfer U; Wenderoth R; Riesenberg D; Plückthun A
    Biotechnology (N Y); 1993 Nov; 11(11):1271-7. PubMed ID: 7764189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain.
    Schoonjans R; Willems A; Schoonooghe S; Leoen J; Grooten J; Mertens N
    Biomol Eng; 2001 Jun; 17(6):193-202. PubMed ID: 11337278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies.
    Schaefer W; Regula JT; Bähner M; Schanzer J; Croasdale R; Dürr H; Gassner C; Georges G; Kettenberger H; Imhof-Jung S; Schwaiger M; Stubenrauch KG; Sustmann C; Thomas M; Scheuer W; Klein C
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11187-92. PubMed ID: 21690412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
    De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
    J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fab chains as an efficient heterodimerization scaffold for the production of recombinant bispecific and trispecific antibody derivatives.
    Schoonjans R; Willems A; Schoonooghe S; Fiers W; Grooten J; Mertens N
    J Immunol; 2000 Dec; 165(12):7050-7. PubMed ID: 11120833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-chain anti-DNA FV.
    Polymenis M; Stollar BD
    Methods Mol Biol; 1995; 51():265-79. PubMed ID: 7581703
    [No Abstract]   [Full Text] [Related]  

  • 15. A new approach to produce IgG
    Zhao C; Zhang W; Gong G; Xie L; Wang MW; Hu Y
    Sci Rep; 2021 Sep; 11(1):18630. PubMed ID: 34545109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
    Shen J; Vil MD; Jimenez X; Iacolina M; Zhang H; Zhu Z
    J Biol Chem; 2006 Apr; 281(16):10706-14. PubMed ID: 16481314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
    Joshi KK; Phung W; Han G; Yin Y; Kim I; Sandoval W; Carter PJ
    MAbs; 2019 Oct; 11(7):1254-1265. PubMed ID: 31286843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
    Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
    Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.
    Schaefer W; Völger HR; Lorenz S; Imhof-Jung S; Regula JT; Klein C; Mølhøj M
    MAbs; 2016; 8(1):49-55. PubMed ID: 26496506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.